EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

Lupberger J., Zeisel MB., Xiao F., Thumann C., Fofana I., Zona L., Davis C., Mee CJ., Turek M., Gorke S., Royer C., Fischer B., Zahid MN., Lavillette D., Fresquet J., Cosset F-L., Rothenberg SM., Pietschmann T., Patel AH., Pessaux P., Doffoël M., Raffelsberger W., Poch O., McKeating JA., Brino L., Baumert TF.

DOI

10.1038/nm.2341

Type

Journal article

Publisher

Springer Science and Business Media LLC

Publication Date

2011-05-01T00:00:00+00:00

Volume

17

Pages

589 - 595

Total pages

6

Permalink More information Close